Uncategorized
Clearside Biomedical closes $20 million series C financing
Clearside Biomedical has completed $20 million in series C financing, the company announced in a press release.Trout Capital served as an adviser to Clearside, and the financing round included new investors Aju IB Investment, Cormorant Asset Management, Perceptive Advisors and Rock Springs Capital Management, along with existing investors, the release said.